Asthma: Accelerated Access Collaborative

(asked on 26th May 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has plans to extend the NHS Accelerated Access Collaborative's rapid uptake programme for severe asthma.


Answered by
Gillian Keegan Portrait
Gillian Keegan
Secretary of State for Education
This question was answered on 9th June 2022

Asthma biologics were selected for tailored support by the Accelerated Access Collaborative’s (AAC) Rapid Uptake Products programme. This aimed to increase adoption in the National Health Service for the treatment of severe asthma in 2021/22. The AAC has now concluded its support following an additional 2,185 patients initiated on asthma biologics through the programme. The Academic Health Sciences Network continues to support NHS organisations to improve access to these medicines in 2022/23.

All asthma biologics are prescribed following a decision by a specialist severe asthma multi-disciplinary team under specialised commissioning arrangements. Severe asthma networks are configured to meet local needs and in some areas biologics may be prescribed in secondary care through these networks, with the appropriate governance in place.

Reticulating Splines